Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coree is a global healthcare and biotechnology company focused on the Mother-Child-Microbiome (MCM) ecosystem, integrating biotechnology, clinical research, and digital health. Founded by Lim Jong-yoon of the Hanmi Pharmaceutical family, the company operates a multi-national R&D network with key hubs in Beijing, Seoul, and Rome. Coree specializes in developing microbiome-based therapeutics for metabolic diseases and obesity, while also providing digital healthcare platforms and specialized nutritional products for maternal and infant health. Through strategic collaborations with institutions like the Gemelli University Hospital, Coree translates clinical microbiome data into innovative diagnostic and therapeutic solutions. The company's portfolio spans from early-stage microbiome research to the commercialization of health supplements and digital therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coree Beijing.